FdaApplication
NDA 020312
Identifiers
- fda_app_no: NDA020312
Properties
| Property | Value |
|---|---|
| applicant_name | UCB INC |
| application_type | NDA |
| approval_date | 1995-04-19 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| UNIVASC | MOEXIPRIL HYDROCHLORIDE | 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
| UNIVASC | MOEXIPRIL HYDROCHLORIDE | 7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
2 products